Biodistribution of progesterone in the eye after topical ocular administration via drops or inserts

dc.centroUniversidad Cardenal Herrera-CEU
dc.contributor.authorAlambiaga Caravaca, Adrián Miguel
dc.contributor.authorGonzález Iglesias, Laura G.
dc.contributor.authorKalia, Yogeshvar N.
dc.contributor.authorRodilla Alama, Vicente
dc.contributor.authorLópez Castellano, Alicia
dc.contributor.otherUCH. Departamento de Farmacia
dc.contributor.otherUCH. Instituto de Ciencias Biomédicas (CEU-ICB)
dc.contributor.otherProducción Científica UCH 2023
dc.date.accessioned2024-01-23T12:40:11Z
dc.date.available2024-01-23T12:40:11Z
dc.date.issued2023-01-05
dc.descriptionEste recurso no está disponible en acceso abierto por política de la editorial.
dc.description.abstractProgesterone (PG) has been shown to have a slowing effect on photoreceptor cell death in mouse models of retinitis pigmentosa when administered orally. The aim of this study was to investigate whether ophthalmically administered progesterone was able to reach neuroretina and thus, the distribution through ocular tissues of different PG formulations was studied. The effect of different initial PG concentration was also investigated. Different formulations with PG in their composition (drops, a corneal/scleral-insert and scleral-inserts) were prepared and assayed. Using whole porcine eyes, the different formulations were topically administered to the ocular surface. Frozen eyes were dissected, the PG in each tissue was extracted in acetonitrile and the amount of PG quantified by UHPLC-MS/MS. Our results show that after topical administration, PG diffuses from the ocular surface and distributes throughout all tissues of the eye. Lower levels of PG were found in sclera, choroid and neuroretina when PG was applied as drops compared to inserts. Our results also show that an increase in the initial PG concentrations applied, resulted in a statistically significant increase in the amounts of PG in aqueous humour, sclera, choroid and neuroretina.es_ES
dc.identifier.citationAlambiaga-Caravaca, A.M., González Iglesias, L.G., Rodilla, V., Kalia, Y.N. & López-Castellano, A. (2023). Biodistribution of progesterone in the eye after topical ocular administration via drops or inserts. International Journal of Pharmaceutics, vol. 630, art. 122453 (05 jan.). DOI: https://doi.org/10.1016/j.ijpharm.2022.122453es_ES
dc.identifier.doihttps://doi.org/10.1016/j.ijpharm.2022.122453
dc.identifier.issn0378-5173
dc.identifier.urihttp://hdl.handle.net/10637/15067
dc.language.isoenes_ES
dc.publisherElsevieres_ES
dc.relationUCH. Financiación Universidad
dc.relationEste artículo de investigación ha sido financiado por la Universidad CEU Cardenal Herrera, (Valencia, España) y la Universidad de Ginebra (Suiza). También, Adrián Alambiaga-Caravaca ha sido beneficiario de una beca predoctoral de la UCH “Ayudas a la formación de Jóvenes Investigadores CEU-SANTANDER 20/21”.
dc.relation.ispartofInternational Journal of Pharmaceutics, vol. 630
dc.rightsrestricted access
dc.rights.cchttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectMedicamento
dc.subjectDrugs
dc.subjectVista
dc.subjectEyesight
dc.subjectEnfermedad
dc.subjectDiseases
dc.subjectFarmacología
dc.subjectPharmacology
dc.titleBiodistribution of progesterone in the eye after topical ocular administration via drops or insertses_ES
dc.typeArtículoes_ES
dspace.entity.typePublicationes
relation.isAuthorOfPublicationb1c460ae-17f0-4260-b073-47506721536c
relation.isAuthorOfPublicationb996c064-4a2e-4a1f-bf71-abdd9d0219aa
relation.isAuthorOfPublication.latestForDiscoveryb1c460ae-17f0-4260-b073-47506721536c

Files

Original bundle

Now showing 1 - 2 of 2
Thumbnail Image
Name:
Biodistribution_Alambiaga_IJP_2023.JPG
Size:
89.96 KB
Format:
Joint Photographic Experts Group/JPEG File Interchange Format (JFIF)
No Thumbnail Available
Name:
Biodistribution_Alambiaga_IJP_2023.pdf
Size:
1.5 MB
Format:
Adobe Portable Document Format

Collections